{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:42Z","timestamp":1793293482215,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018725","name":"Erzurum Technical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Papillary thyroid cancer (PTC) is the most common thyroid malignancy and is often difficult to distinguish from benign nodules using current diagnostic tools, resulting in unnecessary surgical interventions. This study aimed to identify robust, reliable, and non-invasive circulating biomarkers capable of accurately discriminating benign from malignant PTC nodules by elucidating the relationship between thyroid tissue and circulating microRNA\/cytokine profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Paired arterial plasma supplying the thyroid gland and venous plasma draining the gland were collected from patients with benign thyroid nodules and malignant PTC. In addition, preoperative and postoperative peripheral plasma samples were obtained. MicroRNA profiles were compared between arterial inflow and venous outflow to assess thyroid-derived contributions to circulating biomarkers. Differentially expressed microRNAs were validated in preoperative and postoperative peripheral plasma samples and formalin-fixed, paraffin-embedded (FFPE) thyroid tissue sections. Subsequently, cytokine profiles associated with target microRNAs were investigated using cytokine arrays, and selected target proteins were further validated by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Arterial\u2013venous comparisons revealed distinct microRNA and cytokine signatures associated with malignant PTC compared with benign nodules, reflecting tumor-specific release into the circulation. These findings were consistently validated in FFPE tissues and peripheral plasma samples. Importantly, the combined panel of hsa-miR-21-3p, sTNF-RI, IL-12p40, and CCL25 demonstrated high diagnostic performance in distinguishing malignant PTC from benign thyroid lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This integrated tissue-to-circulation approach provides direct evidence that the thyroid microenvironment significantly contributes to the circulating biomarker landscape. The identified biomarker panel represents a promising non-invasive diagnostic tool with the potential to improve PTC diagnosis, reduce unnecessary surgical procedures, and support clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-026-04612-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:14:34Z","timestamp":1777274074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination of hsa-miR-21-3p\/ sTNF-RI\/ IL12-p40 \/CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer"],"prefix":"10.1007","volume":"91","author":[{"given":"Abdulmelik","family":"Aytatli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslisah","family":"Barlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Onur","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Gundogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Tatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"KARATAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"4612_CR1","unstructured":"Hofmann MC, Kunnimalaiyaan M, Wang JRet al. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. Endocr-Relat Cancer 29: R173\u2013R190, 2022; Institute NC. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2024 Sub (1975\u20132022) - Linked To County Attributes - Time Dependent (1990\u20132023) Income\/Rurality, 1969\u20132023 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2025, based on the November 2024 submission. ed.^, eds. NATIONAL CANCER INSTITUTE, 2024."},{"key":"4612_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12, 646\u2013653 (2016)","journal-title":"Nat. Rev. Endocrinol."},{"key":"4612_CR3","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/ijms22041950","volume":"22","author":"JH Yuan","year":"2021","unstructured":"J.H. Yuan, J.Y. Isabella, M. Saied, S. Alfred, C.L. Steve. Xiangpeng Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. International Journal of Molecular Sciences 22: 1950, (2021)","journal-title":"International Journal of Molecular Sciences"},{"key":"4612_CR4","doi-asserted-by":"crossref","unstructured":"K. Yu, X. Wu, L. Dai al. Risk factors associated with lymph node metastasis in papillary thyroid cancer: a retrospective analysis based on 2,428 cases. Frontiers in Oncology 14, L. Croce, M. Teliti, Chytiris Set al. The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology. European Journal of Endocrinology 190: 165\u2013172, 2024","DOI":"10.1093\/ejendo\/lvae012"},{"key":"4612_CR5","doi-asserted-by":"publisher","first-page":"e389708","DOI":"10.1200\/EDBK_389708","volume":"43","author":"S Agosto Salgado","year":"2023","unstructured":"S. Agosto Salgado, E.R. Kaye, Z. Sargi, C.H. Chung, M. Papaleontiou, Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities. Am. Soc. Clin. Oncol. Educ. Book. 43, e389708 (2023)","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"4612_CR6","doi-asserted-by":"crossref","unstructured":"Huber GF, Dziegielewski P, Matthews TW et al. Intraoperative Frozen-Section Analysis for Thyroid Nodules. Archives of Otolaryngology\u2013Head & Neck Surgery 133: 874, 2007; Almquist M, Muth A Surgical management of cytologically indeterminate thyroid nodules. Gland Surgery 8: S105\u2013S111, 2019.","DOI":"10.21037\/gs.2019.01.03"},{"key":"4612_CR7","doi-asserted-by":"crossref","unstructured":"Razavi ZS, Tajiknia V, Majidi S, et al. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles. Crit Rev Oncol Hemat 157, (2021)","DOI":"10.1016\/j.critrevonc.2020.103192"},{"key":"4612_CR8","doi-asserted-by":"crossref","unstructured":"T. Annese, R. Tamma, De M. Giorgis, D. Ribatti microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis. Frontiers in Oncology 10, R. Singh, S.E. Ha, T.Y. Yu, S. Ro, Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers. International Journal of Molecular Sciences 26: 415, (2025)","DOI":"10.3390\/ijms26010415"},{"key":"#cr-split#-4612_CR9.1","doi-asserted-by":"crossref","unstructured":"J.A. Weber, D.H. Baxter, S.L. Zhang, al. The MicroRNA Spectrum in 12 Body Fluids. Clinical Chemistry 56: 1733-1741, 2010","DOI":"10.1373\/clinchem.2010.147405"},{"key":"#cr-split#-4612_CR9.2","doi-asserted-by":"crossref","unstructured":"Ortiz-Quintero B Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif 49: 281-303, 2016","DOI":"10.1111\/cpr.12262"},{"key":"4612_CR10","doi-asserted-by":"crossref","unstructured":"Rocchi A, Chiti E, Maiese A, Turillazzi E, Spinetti I MicroRNAs: An Update of Applications in Forensic Science. Diagnostics 11, 2021; Mayes C, Houston R, Seashols-Williams S, LaRue B, Hughes-Stamm S The stability and persistence of blood and semen mRNA and miRNA targets for body fluid identification in environmentally challenged and laundered samples. Legal Medicine 38: 45\u201350, 2019.","DOI":"10.1016\/j.legalmed.2019.03.007"},{"key":"4612_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/CBM-210504","volume":"36","author":"C Bielak","year":"2023","unstructured":"C. Bielak, A. Arya, S. Savill, Circulating microRNA as potential diagnostic and prognostic biomarkers of well-differentiated thyroid cancer: A review article. Cancer Biomarkers. 36, 193\u2013205 (2023)","journal-title":"Cancer Biomarkers"},{"key":"4612_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"S. Davis, P.S. Meltzer, GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 23, 1846\u20131847 (2007)","journal-title":"Bioinformatics"},{"key":"4612_CR13","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3892\/or.2013.2332","volume":"29","author":"H Saji","year":"2013","unstructured":"H. Saji, M. Tsuboi, Y. Shimada et al., Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence. Oncol. Rep. 29, 1902\u20131906 (2013)","journal-title":"Oncol. Rep."},{"key":"4612_CR14","first-page":"2349","volume":"14","author":"J Dem\u0161ar","year":"2013","unstructured":"J. Dem\u0161ar, T. Curk, A. Erjavec, Orange: Data mining toolbox in python. J. Mach. Learn. Res. 14, 2349\u20132353 (2013)","journal-title":"J. Mach. Learn. Res."},{"key":"4612_CR15","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Z. Gu, R. Eils, M. Schlesner, Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 32, 2847\u20132849 (2016)","journal-title":"Bioinformatics"},{"key":"4612_CR16","doi-asserted-by":"publisher","first-page":"D252","DOI":"10.1093\/nar\/gks1168","volume":"41","author":"S Cho","year":"2012","unstructured":"S. Cho, I. Jang, Y. Jun, miRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res. 41, D252\u2013D257 (2012)","journal-title":"Nucleic Acids Res."},{"key":"4612_CR17","doi-asserted-by":"publisher","first-page":"201306","DOI":"10.1016\/j.humgen.2024.201306","volume":"41","author":"HO Caglar","year":"2024","unstructured":"H.O. Caglar, A. Aytatli, Karatas OF In silico identification of differentially expressed microRNAs in thyroid cancer. Hum. Gene. 41, 201306 (2024)","journal-title":"Hum. Gene"},{"key":"4612_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols. 4: 44\u201357, (2009)","journal-title":"Nature Protocols"},{"key":"4612_CR20","doi-asserted-by":"crossref","unstructured":"Kirschner MB, Edelman JJB, Kao SCH, Vallely MP, Van Zandwijk N, Reid G The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics 4, 2013.","DOI":"10.3389\/fgene.2013.00094"},{"key":"4612_CR21","doi-asserted-by":"publisher","first-page":"146642","DOI":"10.1016\/j.gene.2022.146642","volume":"835","author":"J Kaur","year":"2022","unstructured":"J. Kaur, D. Saul, M.L. Doolittle, Identification of a suitable endogenous control miRNA in bone aging and senescence. Gene. 835, 146642 (2022)","journal-title":"Gene"},{"key":"4612_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"K.J. Livak, T.D. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2009\u2013\u2009\u2206\u2206CT Method. Methods. 25, 402\u2013408 (2001)","journal-title":"Methods"},{"key":"4612_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/cancers12010112","volume":"12","author":"E Minna","year":"2020","unstructured":"E. Minna, S. Brich, Todoerti K, et al. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers. 12, 112 (2020)","journal-title":"Cancers"},{"key":"4612_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 12: 77, (2011)","journal-title":"BMC Bioinformatics"},{"key":"4612_CR25","doi-asserted-by":"crossref","unstructured":"Kuhn M Building Predictive Models inRUsing thecaretPackage. Journal of Statistical Software 28, 2008.","DOI":"10.18637\/jss.v028.i05"},{"key":"4612_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"H. Wickham, M. Averick, Bryan J, et al. Welcome to the Tidyverse. J. Open. Source Softw. 4, 1686 (2019)","journal-title":"J. Open. Source Softw."},{"key":"#cr-split#-4612_CR27.1","unstructured":"Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA Least significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women. J Musculoskelet Neuronal Interact 15: 190-196, 2015"},{"key":"#cr-split#-4612_CR27.2","doi-asserted-by":"crossref","unstructured":"Christgau S, Bitsch-Jensen O, Hanover Bjarnason Net al. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 26: 505-511, 2000.","DOI":"10.1016\/S8756-3282(00)00248-9"},{"key":"4612_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ncrna.2020.06.001","volume":"5","author":"S Ghafouri-Fard","year":"2020","unstructured":"S. Ghafouri-Fard, Z. Shirvani-Farsani, M. Taheri, The role of microRNAs in the pathogenesis of thyroid cancer. Non-coding RNA Res. 5, 88\u201398 (2020)","journal-title":"Non-coding RNA Res."},{"key":"4612_CR29","doi-asserted-by":"publisher","first-page":"e16660","DOI":"10.7717\/peerj.16660","volume":"12","author":"J Li","year":"2024","unstructured":"J. Li, Z. Chen, Q. Li et al., Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer. PeerJ. 12, e16660 (2024)","journal-title":"PeerJ"},{"key":"4612_CR30","doi-asserted-by":"publisher","first-page":"154516","DOI":"10.1016\/j.prp.2023.154516","volume":"246","author":"TD Antonia","year":"2023","unstructured":"T.D. Antonia, L.I. Maria, G.-G. Ancuta-Augustina, Preoperative evaluation of thyroid nodules \u2013 Diagnosis and management strategies. Pathol. - Res. Pract. 246, 154516 (2023)","journal-title":"Pathol. - Res. Pract."},{"key":"4612_CR31","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.3390\/jcm14155551","volume":"14","author":"L De La Ruiz-Hern\u00e1ndez","year":"2025","unstructured":"L. Ruiz-Hern\u00e1ndez, C.R. Hern\u00e1ndez-Socorro, P. Saavedra, De La M. Vega-P\u00e9rez, S. Ruiz-Santana, Assessment of Ultrasound-Controlled Diagnostic Methods for Thyroid Lesions and Their Associated Costs in a Tertiary University Hospital in Spain. J. Clin. Med. 14, 5551 (2025)","journal-title":"J. Clin. Med."},{"key":"4612_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/01.3001.0012.4712","volume":"90","author":"E Macha\u0142a","year":"2018","unstructured":"E. Macha\u0142a, J. Sopi\u0144ski, I. Iavorska, K. Ko\u0142omecki, Correlation of Fine Needle Aspiration Cytology of Thyroid Gland with Histopathological Results. Pol. J. Surg. 90, 1\u20135 (2018)","journal-title":"Pol. J. Surg."},{"key":"4612_CR33","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.3390\/ijms26115173","volume":"26","author":"A Forma","year":"2025","unstructured":"A. Forma, K. K\u0142odnicka, W. Paj\u0105k, Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies. Int. J. Mol. Sci. 26, 5173 (2025)","journal-title":"Int. J. Mol. Sci."},{"key":"4612_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/jpm15070324","volume":"15","author":"E Battistella","year":"2025","unstructured":"E. Battistella, L. Pomba, R. Toniato, A. Piotto, A. Toniato, Total Thyroidectomy vs. Lobectomy in Papillary Thyroid Microcarcinoma: A Contested Gold Standard. J. Personalized Med. 15, 324 (2025)","journal-title":"J. Personalized Med."},{"key":"#cr-split#-4612_CR35.1","doi-asserted-by":"crossref","unstructured":"Li J, Vasilyeva E, Wiseman SM Beyond immunohistochemistry and immunocytochemistry: a current perspective on galectin-3 and thyroid cancer. Expert Review of Anticancer Therapy 19: 1017-1027, 2019","DOI":"10.1080\/14737140.2019.1693270"},{"key":"#cr-split#-4612_CR35.2","doi-asserted-by":"crossref","unstructured":"I\u0161i\u0107 T, Savin S, Cveji\u0107 Det al. Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors. Journal of Cancer Research and Clinical Oncology 136: 1805-1812, 2010.","DOI":"10.1007\/s00432-010-0838-3"},{"key":"4612_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5152\/UCD.2015.2928","volume":"31","author":"E Yilmaz","year":"2015","unstructured":"E. Yilmaz, T. Karsidag, C. Tatar, S. Tuzun, Serum Galectin-3: diagnostic value for papillary thyroid carcinoma. Turkish J. Surg. 31, 192\u2013196 (2015)","journal-title":"Turkish J. Surg."},{"key":"#cr-split#-4612_CR37.1","doi-asserted-by":"crossref","unstructured":"Prasad PA, Raju K Diagnostic utility of CK19 and galectin-3 in differentiating papillary thyroid carcinoma from nonneoplastic lesions of thyroid. Journal of Cancer Research and Therapeutics 18: 644-649, 2022","DOI":"10.4103\/jcrt.jcrt_563_21"},{"key":"#cr-split#-4612_CR37.2","doi-asserted-by":"crossref","unstructured":"Bose D, Das RN, Chatterjee U, Banerjee U Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma. Indian Journal of Medical and Paediatric Oncology 33: 107-111, 2012.","DOI":"10.4103\/0971-5851.99746"},{"key":"4612_CR38","doi-asserted-by":"crossref","unstructured":"Noroozinia F Ck19 is a Useful Marker in Distinguishing Follicular Variant of Papillary Thyroid Carcinoma from Benign Thyroid Lesions with Follicular Growth Pattern. Acta Endocrinologica (Bucharest) 12: 387\u2013391, 2016.","DOI":"10.4183\/aeb.2016.387"},{"key":"4612_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1916-0216-42-16","volume":"42","author":"FM Makki","year":"2013","unstructured":"F.M. Makki, S.M. Taylor, Shahnavaz A, et al. Serum biomarkers of papillary thyroid cancer. J. Otolaryngol. - Head Neck Surg. 42, 16 (2013)","journal-title":"J. Otolaryngol. - Head Neck Surg."},{"key":"4612_CR40","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"P.S. Mitchell, R.K. Parkin , Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences 105: 10513\u201310518 (2008)","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"4612_CR41","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Y. Peng, C.M. Croce, The role of MicroRNAs in human cancer. Signal. Transduct. Target. Therapy. 1, 15004 (2016)","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"4612_CR42","doi-asserted-by":"crossref","unstructured":"Syed SN, Brune B MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment. Cancers (Basel) 12, 2020.","DOI":"10.3390\/cancers12040911"},{"key":"4612_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cells10030607","volume":"10","author":"ECF Yeo","year":"2021","unstructured":"E.C.F. Yeo, M.P. Brown, T. Gargett, L.M. Ebert, The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy. Cells. 10, 607 (2021)","journal-title":"Cells"},{"key":"4612_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2008.11.010","volume":"45","author":"AJ Asirvatham","year":"2009","unstructured":"A.J. Asirvatham, W.J. Magner, Tomasi TB miRNA regulation of cytokine genes. Cytokine. 45, 58\u201369 (2009)","journal-title":"Cytokine"},{"key":"4612_CR45","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1158\/1541-7786.MCR-15-0147","volume":"13","author":"SAA Patel","year":"2015","unstructured":"S.A.A. Patel, N.J. Gooderham, IL6 Mediates Immune and Colorectal Cancer Cell Cross-talk\u2009<\u2009i>via\u2009miR-21 and miR-29b. Mol. Cancer Res. 13, 1502\u20131508 (2015)","journal-title":"Mol. Cancer Res."},{"key":"4612_CR46","doi-asserted-by":"publisher","first-page":"e0134366","DOI":"10.1371\/journal.pone.0134366","volume":"10","author":"B Dong","year":"2015","unstructured":"B. Dong, Z. Shi, J. Wang, J. Wu, Z. Yang, K. Fang, IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer. PLOS ONE. 10, e0134366 (2015)","journal-title":"PLOS ONE"},{"key":"4612_CR47","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/jcm12093127","volume":"12","author":"S Maryam","year":"2023","unstructured":"S. Maryam, K. Krukiewicz, I.U. Haq, A.A. Khan, G. Yahya, S. Cavalu, Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring. J. Clin. Med. 12, 3127 (2023)","journal-title":"J. Clin. Med."},{"key":"4612_CR48","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1074\/jbc.M112.436675","volume":"288","author":"R Jalah","year":"2013","unstructured":"R. Jalah, M. Rosati, B. Ganneru, The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit. J. Biol. Chem. 288, 6763\u20136776 (2013)","journal-title":"J. Biol. Chem."},{"key":"4612_CR49","first-page":"1","volume":"2014","author":"LS Ward","year":"2014","unstructured":"L.S. Ward, Immune Response in Thyroid Cancer, Widening Boundaries Scientifica. 2014, 1\u201320 (2014)","journal-title":"Widening Boundaries Scientifica"},{"key":"#cr-split#-4612_CR50.1","unstructured":"Minbo J, Feng C, Wen Het al. Up-regulated and hypomethylated genes are causative factors and diagnostic markers of osteoporosis. Am J Transl Res 15: 6042-6057, 2023"},{"key":"#cr-split#-4612_CR50.2","doi-asserted-by":"crossref","unstructured":"Shen L, Zhang H, Zhou X, Liu R Association between polymorphisms of interleukin 12 and rheumatoid arthritis associated biomarkers in a Chinese population. Cytokine 76: 363-367, 2015.","DOI":"10.1016\/j.cyto.2015.09.007"},{"key":"4612_CR51","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.3748\/wjg.v18.i38.5360","volume":"18","author":"K Hosono","year":"2012","unstructured":"K. Hosono, Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas. World J. Gastroenterol. 18, 5360 (2012)","journal-title":"World J. Gastroenterol."},{"key":"4612_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews Immunology. 17: 559\u2013572, (2017)","journal-title":"Nature Reviews Immunology"},{"key":"4612_CR53","doi-asserted-by":"crossref","unstructured":"Rabin RL. CC, C, and CX3C Chemokines. ed.^, eds.: Elsevier, 2003; 255\u2013263.","DOI":"10.1016\/B0-12-341103-3\/00044-9"},{"key":"4612_CR54","doi-asserted-by":"crossref","unstructured":"Gupta P, Sharma PK, Mir Het al. CCR9\/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget 5: 10170\u201310179, 2014; Murata D, Azuma K, Murotani Ket al. Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1\/L1 inhibitor monotherapy. Cancer Immunology, Immunotherapy 73, 2024.","DOI":"10.18632\/oncotarget.2526"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04612-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:46:50Z","timestamp":1781650010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4612"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04612-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ataturk University Faculty of Medicine Institutional Review Board under decision number B.30.2.ATA.0.01.00\/263.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"AA, AS, NB, HOC, BG, and AT declare that they have no conflict of interests. OFK holds stocks in EcoTech Biotechnology. The terms of this arrangement have been reviewed and approved by Erzurum Technical University in accordance with its policy on objectivity in research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Process During the preparation of this work the authors used ChatGPT OpenAI (OpenAI Ireland Ltd, Dublin, Ireland) for spell checking. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI\u2011Assisted Technologies in the Writing"}}],"article-number":"146"}}